The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Atyr Pharma Inc’s current trading price is -2.34% away from its 52-week high, while its distance from the 52-week low is 269.62%. The stock’s price range for this period has been between $1.58 and $5.98 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.71 million for the day, a number notably higher than the average daily volume of 2.43 million over the last three months.
At present, Atyr Pharma Inc (ATYR) has a stock price of $5.84. In the previous session, the stock saw a rise, peaking at $35.0 after an opening price of $5.84. The day’s lowest price was $9.0, and it closed at $5.63.
Atyr Pharma Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $5.98 on 06/10/25, while the lowest value for the same period was recorded at $1.58 on 07/22/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Atyr Pharma Inc (ATYR) has experienced a quarterly rise of 94.02% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 519.79M and boasts a workforce of 59 employees.
Atyr Pharma Inc: What Analysts Are Saying
As of right now, 7 analysts are rating Atyr Pharma Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.00, with a change in price of +1.41. Similarly, Atyr Pharma Inc recorded 2,160,408 in trading volume during the last 100 days, posting a change of +31.83%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ATYR stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.16.
ATYR Stock Stochastic Average
Atyr Pharma Inc’s raw stochastic average for the past 50 days is presently 95.33%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 92.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 89.78% and 80.13%, respectively.
ATYR Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 235.63%.However, over the last six months, we can see a weaker performance of 77.51%. Over the last 30 days, the price of ATYR has fallen by 12.31%. And in the last five days, it has surged by 5.61%.
